cell therapies

Oncology

CAR-NK cell therapies for solid tumours: Closing the gap bet...

CAR-NK cell therapies are frequently misunderstood, despite growing clinical and preclinical data supporting their potential.

R&D

Biotech’s biggest challenge isn’t scientific, but political ...

We speak to James Roosevelt Jr, a longtime healthcare leader, former associate commissioner of social security for retirement policy & grandson of FDR

News

Iovance cuts staff on slower cell therapy sales growth

Iovance will slash 19% of its headcount in a restructuring that follows slower-than-expected sales growth for melanoma cell therapy Amtagvi.

News

ADA: Vertex closer to weaning type 1 diabetics off insulin

A cell therapy developed by Vertex Pharma has allowed 10 of 12 patients with type 1 diabetes to control their blood sugar without insulin.

R&D

Cell therapy transportation and storage with hydrogels

Hydrogels are revolutionising cell therapy storage – discover how they tackle cold chain challenges and reduce costs while preserving cell viability.

News

AstraZeneca buys cell therapy biotech for up to $1bn

AstraZeneca plans to acquire Belgian in vivo cell therapy biotech EsoBiotec and has signed a pair of licensing deals with drug delivery firm Alteogen.

CAR-NK cell therapies for solid tumours: Closing the gap bet...

Biotech’s biggest challenge isn’t scientific, but political ...

Iovance cuts staff on slower cell therapy sales growth

ADA: Vertex closer to weaning type 1 diabetics off insulin

Cell therapy transportation and storage with hydrogels

AstraZeneca buys cell therapy biotech for up to $1bn

Doctors dismayed by report of NHS AI proposal

Discover a new era of healthcare panel engagement: Grounded ...

cell therapies

Editor's Picks